etorphine has been researched along with Substance Withdrawal Syndrome in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 7 (38.89) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 1 (5.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freye, E; Levy, JV | 1 |
| Katz, JL; Medzihradsky, F; Smith, CB; Winger, GD; Woods, JH | 1 |
| Huang, M; Qin, BY | 1 |
| Katz, JL; Medzihradsky, F; Valentino, RJ; Woods, JH | 1 |
| Gambino, MC; Petrillo, P; Tavani, A | 1 |
| Busse, LW; Fujimoto, JM; Lange, DG; Roerig, SC | 1 |
| Kalant, H; Mucha, RF | 1 |
| Miao, H; Qin, BY | 1 |
| Kaneto, H; Nakamura, F; Takahashi, M; Tokuyama, S | 1 |
| Cai, ZJ; Ge, Y; Li, M; Sun, WL | 1 |
| Freye, E; Neruda, B; Smith, OW | 1 |
| Harris, LS; Kim, SA; Martin, TJ; Smith, JE | 1 |
| Crain, SM; Shen, KF | 1 |
| Bai, HQ; Li, N; Li, Y; Wu, WR; Zhang, KR; Zheng, JW | 1 |
| Aceto, MD; Harris, LS; Ji, Z; Scates, SM | 1 |
| Dum, J; Herz, A; Höllt, V; Meyer, G | 1 |
| Bläsig, J; Dum, J; Herz, A; Höllt, V; Schubert, P | 1 |
| Aceto, MD; Bowman, ER; Harris, LS; Jacobson, AE; May, EL; Medzihradsky, F; Smith, CB; Woods, JH | 1 |
18 other study(ies) available for etorphine and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil.
Topics: Afferent Pathways; Analgesics, Opioid; Animals; Blood Pressure; Bradycardia; Dogs; Dose-Response Relationship, Drug; Etorphine; Evoked Potentials, Somatosensory; Heart Rate; Hyperalgesia; Hypotension; Naloxone; Narcotic Antagonists; Piperidines; Remifentanil; Substance Withdrawal Syndrome; Sufentanil | 2010 |
Evaluation of new compounds for opioid activity (1983).
Topics: Animals; Binding, Competitive; Drug Evaluation; Etorphine; Guinea Pigs; Humans; Macaca mulatta; Mice; Muscle Contraction; Muscle, Smooth; Narcotic Antagonists; Narcotics; Nociceptors; Opioid-Related Disorders; Receptors, Opioid; Substance Withdrawal Syndrome | 1984 |
[Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
Topics: Analgesics; Animals; Etorphine; Female; Humans; Macaca mulatta; Male; Mice; Morphinans; Morphine Dependence; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1982 |
Receptor binding, antagonist, and withdrawal precipitating properties of opiate antagonists.
Topics: Animals; Binding, Competitive; Brain; Cell Membrane; Etorphine; Humans; Ileum; Kinetics; Macaca mulatta; Male; Morphine Dependence; Muscle Contraction; Naloxone; Narcotic Antagonists; Rats; Rats, Inbred Strains; Receptors, Opioid; Structure-Activity Relationship; Substance Withdrawal Syndrome | 1983 |
Bremazocine induces antinociception, but prevents opioid-induced constipation and catatonia in rats and precipitates withdrawal in morphine-dependent rats.
Topics: Analgesics; Animals; Benzomorphans; Catatonia; Constipation; Dose-Response Relationship, Drug; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Etorphine; Gastrointestinal Motility; Humans; Male; Morphinans; Morphine; Naloxone; Rats; Substance Withdrawal Syndrome; Substance-Related Disorders | 1984 |
Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
Topics: Animals; Dose-Response Relationship, Drug; Drug Implants; Drug Tolerance; Etorphine; Heroin; Humans; Male; Methadone; Mice; Morphine; Narcotics; Opioid-Related Disorders; Solubility; Substance Withdrawal Syndrome | 1983 |
Log dose/response curve flattening in rats after daily injection of opiates.
Topics: Analgesics; Animals; Body Temperature; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Humans; Morphine; Narcotics; Rats; Reaction Time; Substance Withdrawal Syndrome | 1980 |
Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
Topics: Animals; Body Weight; Etorphine; Female; Locus Coeruleus; Male; Morphine Dependence; Neurons; Opioid-Related Disorders; Rats; Rats, Wistar; Reserpine; Substance Withdrawal Syndrome | 1995 |
Physical dependence produced by dihydroetorphine in mice.
Topics: Analgesics; Animals; Etorphine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome | 1994 |
[Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
Topics: Administration, Sublingual; Adolescent; Adult; Analgesics, Opioid; Etorphine; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders | 1994 |
Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil.
Topics: Alfentanil; Analgesics, Opioid; Animals; Blood Gas Analysis; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Etorphine; Fentanyl; Heart Rate; Naloxone; Narcotic Antagonists; Receptors, Opioid, mu; Substance Withdrawal Syndrome | 1997 |
Potent reinforcing effects of dihydroetorphine in rats.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Etorphine; Fentanyl; Heroin; Male; Morphine; Morphine Derivatives; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice.
Topics: Administration, Oral; Analgesics, Opioid; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Etorphine; Infusions, Parenteral; Male; Mice; Mice, Inbred Strains; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Nociceptors; Substance Withdrawal Syndrome; Substance-Related Disorders | 1997 |
Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
Topics: Analgesics, Opioid; Animals; Antibody-Producing Cells; Body Weight; Cell Division; Dose-Response Relationship, Drug; Etorphine; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Lymphokines; Mice; Mice, Inbred C57BL; Naloxone; Opioid-Related Disorders; Organ Size; Spleen; Substance Withdrawal Syndrome; Thymus Gland | 1999 |
Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Etorphine; Infusions, Parenteral; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2000 |
In vivo opiate binding unchanged in tolerant/dependent mice.
Topics: Animals; Binding, Competitive; Cerebellum; Drug Tolerance; Etorphine; Humans; Mice; Morphine; Morphine Dependence; Naloxone; Narcotics; Substance Withdrawal Syndrome; Time Factors | 1979 |
Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant dependent rodents.
Topics: Animals; Autoradiography; Brain; Cyclopropanes; Drug Tolerance; Etorphine; Humans; Levallorphan; Mice; Morphine; Naloxone; Opium; Pain; Rats; Receptors, Drug; Stereoisomerism; Structure-Activity Relationship; Substance Withdrawal Syndrome; Substance-Related Disorders | 1975 |
Very long-acting narcotic antagonists: the 14 beta-p-substituted cinnamoylaminomorphinones and their partial mu agonist codeinone relatives.
Topics: Analgesics; Animals; Cinnamates; Codeine; Electric Stimulation; Etorphine; In Vitro Techniques; Macaca mulatta; Male; Mice; Mice, Inbred ICR; Morphine Derivatives; Muscle, Smooth; Narcotic Antagonists; Receptors, Opioid; Receptors, Opioid, mu; Substance Withdrawal Syndrome; Substance-Related Disorders; Vas Deferens | 1989 |